## Abstract Diffuse large Bโcell lymphoma (DLBCL) is a biologically heterogeneous disease for which the current approach to treatment is only successful for 50% of patients. The prognostic value of various clinical and biological factors in predicting treatment outcome is discussed in this paper. A
Prognostic significance of clinical and pathologic features in diffuse large B-cell lymphoma
โ Scribed by Hirokazu Nakamine; Dennis D. Weisenburger; Robert G. Bagin; Julie M. Vose; Martin A. Bast; Philip J. Bierman; James O. Armitage
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 685 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Recent studies have suggested that chromosomal aberrations of the MYC gene locus indicate an unfavorable prognosis in diffuse large Bโcell lymphoma (DLBCL). However, there have been few reports on MYC translocation in Chinese patients. One hundred and six cases of DLBCLs were analyzed u
Clinicopathologic correlations were made in 50 patients with follicular large cell (FLC) lymphoma to better define the influence of a variety of clinical and pathologic features on survival and the potential for continuous freedom from disease. The 5and 10-year actuarial survivals for the entire gro
Prognosis of DLCL patients is variable and associated with well-deยฎned risk factors. In the past decade several pretreatment variables have been incorporated into prognostic models to predict the death risk of individual patients. The International Prognostic Index (IPI), developed in an internation